MedPath

To compare the effect of Madhu Shigru Aschyotana and Jatimukuladi Varti in the management of simple allergic conjunctivitis

Not yet recruiting
Conditions
people suffering from simple allergic conjunctivitis
Other conjunctivitis,
Registration Number
CTRI/2019/02/017484
Lead Sponsor
All Iindia Institute of Ayurveda
Brief Summary

A clinical trial for comparing the efficacy of madhu shigru aschyotana and jatimukuladi varti in the management of kaphaj abhishyanda with special referance to simple allergic conjunctivitis.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

itching mucus ropy discharge repeated lacrimation heviness of lids photophobia foreign body sensation burning sensation mid papillary response hyperemia chemosis.

Exclusion Criteria

patients not willing for trial and follow up viral and bacterial conjunctivitis vernal keratoconjunctivitis atopic keratoconjunctivitis giant papillary conjunctivitis phlyctenular conjunctivitis trachoma chalazion stye pterygium dacryocystitis trichiasis corneal opacity corneal ulcerrs hypertension diabetes mellitus tuberculosis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
to compare the efficacy of jatimukuladi varti and madhu shigru aschyotana in the management of kaphaj abhishyanda3 weeks of Administration of Drugs
Secondary Outcome Measures
NameTimeMethod
To Restore or Maintain Normal Visual FunctionTo Prevent or Reduce the Likelihood of Damage to the Ocular Surface in respect to Allergic Conjunctivitis

Trial Locations

Locations (1)

All India Institute of Ayurveda

🇮🇳

South, DELHI, India

All India Institute of Ayurveda
🇮🇳South, DELHI, India
dr nidhi verma
Principal investigator
8810251767
nidz.bhu@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.